structure glp 1 of the GLP-1-bound ECD of the GLP-1R. A, stereoview of GLP-1 Glucagon-like peptide-1 receptor - Wikipedia

Injection Administration: The injection is administered intramuscularly, typically in the arm, thigh, or buttocks

What the Research Does NOT Yet Support - There are currently no published randomised controlled trials (RCTs) in humans for BPC-157 - Human pharmacokinetic data (how it is absorbed, distributed, metabolised, and excreted) is limited - Optimal dosing, route of administration, and treatment duration have not been established clinically - Long-term safety data in humans is absent - Regulatory approval from the TGA, FDA, or EMA has not been granted for any therapeutic indication TB-500: Evidence Overview What the Research Supports TB-500 / Thymosin Beta-4 has somewhat more human-facing research, though still predominantly preclinical: Phase I and II clinical trials have investigated Thymosin Beta-4 (the native peptide) in cardiac repair following myocardial infarction, with promising safety profiles Wound healing applications have been explored in clinical settings, particularly for chronic non-healing wounds and dry eye disease Robust animal evidence supports its role in reducing inflammation, supporting angiogenesis, and promoting tissue regeneration The native peptide (T4) has demonstrated cardioprotective effects in animal models of heart failure and ischaemia What the Research Does NOT Yet Support TB-500 is a synthetic fragment of T4 it is not identical to the native peptide, and extrapolating human clinical data from T4 studies directly to TB-500 may not be valid No approved therapeutic indications exist for TB-500 specifically Comparative efficacy versus established treatments has not been studied The long-term effects of exogenous peptide administration on endogenous thymosin beta-4 regulation are unknown Potential Benefits: A Summary Based on the available (predominantly preclinical) literature, the following potential benefits have been identified: Risks & Safety Considerations Known & Reported Side Effects Because large-scale human trials are lacking, our understanding of the side effect profile is limited

Potential candidates may include individuals seeking support for: Healthy Aging People interested in: Longevity optimization Biological age reduction Preventive medicine Health span enhancement Poor Sleep Quality Individuals experiencing: Fragmented sleep Age-related sleep decline Circadian rhythm disruption Recovery and Regeneration Those seeking support for: Cellular repair Recovery capacity Physical resilience High Oxidative Stress People exposed to: Chronic stress Environmental toxins Metabolic dysfunction Accelerated aging processes Longevity and Biohacking Programs Epitalon is increasingly incorporated into physician-guided longevity protocols focused on: Biological age optimization Cellular health Mitochondrial support Anti-aging medicine Epitalon and Biological Age Chronological age reflects how many years you have lived

Results were normalized by total DNA or number of islets

Together the two represent distinct but converging mechanisms studied in metabolic research

Todays Top 3 Takeaways: The topical delivery method of glutathione is far superior to oral, consumable, IV forms of delivery